126 related articles for article (PubMed ID: 34091135)
1. Are baseline mammographic and ultrasound features associated with metastasis free survival in women receiving neoadjuvant chemotherapy for invasive breast cancer?
Evans A; Sim YT; Whelehan P; Savaridas S; Jordan L; Thompson A
Eur J Radiol; 2021 Aug; 141():109790. PubMed ID: 34091135
[TBL] [Abstract][Full Text] [Related]
2. Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?
Savaridas SL; Sim YT; Vinnicombe SJ; Purdie CA; Thompson AM; Evans A
Cancer Imaging; 2019 Oct; 19(1):67. PubMed ID: 31639053
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review of MRI features associated with metastasis-free survival in women with breast cancer: focusing on skin thickening and skin enhancement.
Mberu V; McFarlane J; Macaskill EJ; Evans A
Br J Radiol; 2021 Dec; 94(1128):20210472. PubMed ID: 34591686
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy response of breast cancer: Prospective comparison with magnetic resonance and mammography.
Conz L; Jales RM; Dória MT; Melloni I; Cres Lyrio CA; Menossi C; Derchain S; Sarian LO
PLoS One; 2024; 19(6):e0302527. PubMed ID: 38833499
[TBL] [Abstract][Full Text] [Related]
5. Identification of pathological complete response after neoadjuvant chemotherapy for breast cancer: comparison of greyscale ultrasound, shear wave elastography, and MRI.
Evans A; Whelehan P; Thompson A; Purdie C; Jordan L; Macaskill J; Henderson S; Vinnicombe S
Clin Radiol; 2018 Oct; 73(10):910.e1-910.e6. PubMed ID: 29980324
[TBL] [Abstract][Full Text] [Related]
6. Comparison of strain and shear-wave ultrasounic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers.
Ma Y; Zhang S; Li J; Li J; Kang Y; Ren W
Eur Radiol; 2017 Jun; 27(6):2282-2291. PubMed ID: 27752835
[TBL] [Abstract][Full Text] [Related]
7. The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease.
Evans A; Sim YT; Lawson B; Macaskill J; Jordan L; Thompson A
Breast Cancer; 2022 Mar; 29(2):296-301. PubMed ID: 34780035
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of shear-wave elastography versus dynamic optical breast imaging for predicting the pathological response to neoadjuvant chemotherapy in breast cancer.
Zhang J; Tan X; Zhang X; Kang Y; Li J; Ren W; Ma Y
Eur J Radiol; 2020 Aug; 129():109098. PubMed ID: 32559591
[TBL] [Abstract][Full Text] [Related]
9. Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer?
Evans AJ; Pinder SE; James JJ; Ellis IO; Cornford E
AJR Am J Roentgenol; 2006 Nov; 187(5):1377-80. PubMed ID: 17056932
[TBL] [Abstract][Full Text] [Related]
10. Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer.
Gu J; Polley EC; Denis M; Carter JM; Pruthi S; Gregory AV; Boughey JC; Fazzio RT; Fatemi M; Alizad A
Breast Cancer Res; 2021 Apr; 23(1):52. PubMed ID: 33926522
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer Comparing Interim Ultrasound, Shear Wave Elastography and MRI.
Evans A; Whelehan P; Thompson A; Purdie C; Jordan L; Macaskill J; Waugh S; Fuller-Pace F; Brauer K; Vinnicombe S
Ultraschall Med; 2018 Aug; 39(4):422-431. PubMed ID: 28934812
[TBL] [Abstract][Full Text] [Related]
12. Non-histopathological parameters associated with upgrade of breast tumours yielding a core biopsy report of histological grade 2 ductal no special type to grade 3 on excision.
Ahmeidat H; Purdie C; Jordan L; Fleming D; McCullough J; Evans A
Eur J Surg Oncol; 2018 Nov; 44(11):1720-1724. PubMed ID: 30150157
[TBL] [Abstract][Full Text] [Related]
13. Combining conventional ultrasound and sonoelastography to predict axillary status after neoadjuvant chemotherapy for breast cancer.
Huang JX; Lin SY; Ou Y; Shi CG; Zhong Y; Wei MJ; Pei XQ
Eur Radiol; 2022 Sep; 32(9):5986-5996. PubMed ID: 35364714
[TBL] [Abstract][Full Text] [Related]
14. Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer After the Second Cycle of Chemotherapy Using Shear-Wave Elastography-A Preliminary Evaluation.
Singh T; Kumar N; Sandhu M; Singla V; Singh G; Bal A
Ultrasound Q; 2021 Mar; 37(1):16-22. PubMed ID: 33661797
[TBL] [Abstract][Full Text] [Related]
15. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?
Maier AM; Heil J; Harcos A; Sinn HP; Rauch G; Uhlmann L; Gomez C; Stieber A; Funk A; Barr RG; Hennigs A; Riedel F; Schäfgen B; Hug S; Marmé F; Sohn C; Golatta M
Eur J Radiol; 2020 Jul; 128():109025. PubMed ID: 32371182
[TBL] [Abstract][Full Text] [Related]
16. Human Epidermal Growth Factor 2-positive Breast Cancer with Mammographic Microcalcification: Relationship to Pathologic Complete Response after Neoadjuvant Chemotherapy.
Mazari FAK; Sharma N; Dodwell D; Horgan K
Radiology; 2018 Aug; 288(2):366-374. PubMed ID: 29786482
[TBL] [Abstract][Full Text] [Related]
17. Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.
Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
Cancer Causes Control; 2021 Mar; 32(3):251-260. PubMed ID: 33377172
[TBL] [Abstract][Full Text] [Related]
18. Early Evaluation of Relative Changes in Tumor Stiffness by Shear Wave Elastography Predicts the Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Jing H; Cheng W; Li ZY; Ying L; Wang QC; Wu T; Tian JW
J Ultrasound Med; 2016 Aug; 35(8):1619-27. PubMed ID: 27302898
[TBL] [Abstract][Full Text] [Related]
19. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
[TBL] [Abstract][Full Text] [Related]
20. Pathological and mammographic prognostic factors for screen detected cancers in a multi-centre randomised, controlled trial of mammographic screening in women from age 40 to 48 years.
Bennett RL; Evans AJ; Kutt E; Record C; Bobrow LG; Ellis IO; Hanby A; Moss SM
Breast; 2011 Dec; 20(6):525-8. PubMed ID: 21696957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
